Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(2-amino–3–phenyl–bicyclo[2.2.1]hept–₂–yl)–phenyl–methanone is a synthetic small molecule with the molecular formula C20H21NO and a molecular weight of approximately 291 Da.[1][9][7] It features a norbornane (bicyclo[₂․₂․₁]heptane) core substituted with amino and phenyl groups as well as a benzoyl moiety.[6][9][7] This compound is classified as an experimental chemical entity; there are no known approved pharmaceutical uses or clinical indications for this molecule at present.[7][10] Its mechanism of action and biological targets have not been characterized in the literature or major drug databases to date.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (2-amino-3-phenyl-bicyclo[2.2.1]hept-2-yl)-phenyl-methanone.